Event
Upcoming Live Webinar: Overcoming formulation challenges for complex programs: Integrated strategies for Poor Solubility, Modified Release & Pediatrics
Drug development for any molecule type is challenging, given the numerous stages an active lead molecule or new chemical entity (NCE) must transition through to gain regulatory approval and reach patients to demonstrate its benefits. For more complex molecules that may require having solubility enhancement or specialized formulation expertise like modified release or a pediatric program, the challenges in achieving clinical and commercial success are even greater.
